Cargando…
Osteopontin -- a promising biomarker for cancer therapy
Osteopontin (OPN), a multifunctional protein, has emerged as a potentially valuable biomarker for diagnosing and treating cancers. Recent research focuses on its involvement in tumor biology including the cell proliferation, survival, angiogenesis, invasion, and metastasis. Understanding the molecul...
Autores principales: | Wei, Ran, Wong, Janet Pik Ching, Kwok, Hang Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560134/ https://www.ncbi.nlm.nih.gov/pubmed/28819419 http://dx.doi.org/10.7150/jca.20480 |
Ejemplares similares
-
In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer
por: Wei, Ran, et al.
Publicado: (2018) -
Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer
por: Wong, Janet P.C., et al.
Publicado: (2017) -
Osteopontin as a biomarker for osteosarcoma therapy and prognosis
por: Han, Xingwen, et al.
Publicado: (2019) -
Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis
por: Abdelaziz Mohamed, Iman, et al.
Publicado: (2019) -
Osteopontin as a Biomarker in Chronic Kidney Disease
por: Sinha, Satyesh K., et al.
Publicado: (2023)